Search

Your search keyword '"Drug Delivery Systems adverse effects"' showing total 1 results
Start Over Descriptor "Drug Delivery Systems adverse effects" Region europe

Refine your results

1 results on '"Drug Delivery Systems adverse effects"'

1. Fentanyl transdermal system: market withdrawal. Exposes patients to a risk of overdose. The market withdrawal, due to a manufacturing defect, is more than welcome.

Subjects
Administration, Cutaneous, Consumer Product Safety, Device Approval, Drug Approval, Drug Delivery Systems instrumentation, Equipment Failure, Europe, Fentanyl administration & dosage, Fentanyl therapeutic use, Humans, Iontophoresis instrumentation, Marketing of Health Services, Quality Control, Drug Delivery Systems adverse effects, Drug Overdose, Fentanyl adverse effects, Iontophoresis adverse effects
Published
2009

Catalog

Books, media, physical & digital resources
See catalog results